| Status: | Phase 2 |
| Entry Type: | Small molecule |
| Molecule Category: | UNKNOWN |
| UNII: | Q2U4R164OG |
| Property Name | Value |
|---|---|
| Molecular Formula | C20H21F2N3O |
| Molecular Weight | 357.4 |
| AlogP | 2.8 |
| Hydrogen Bond Acceptor | 3.0 |
| Hydrogen Bond Donor | 1.0 |
| Number of Rotational Bond | 4.0 |
| Polar Surface Area | 45.23 |
| Molecular species | None |
| Aromatic Rings | 2.0 |
| Heavy Atoms | 26.0 |
| Action | Mechanism of Action | Reference |
|---|---|---|
| AGONIST | Neuronal acetylcholine receptor protein alpha-7 subunit agonist |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Asthma | 2 | D001249 | ClinicalTrials |
| Diabetes Mellitus, Type 2 | 2 | D003924 | ClinicalTrials |
| Resources | Reference |
|---|---|
| CAS NUMBER | 1196701-27-5 |
| ChEMBL | CHEMBL3545410 |
| FDA SRS | Q2U4R164OG |
| PubChem | 44511587 |